Soluble CD21 (sCD21) forms biologically active complexes with CD23: sCD21 is present in normal plasma as a complex with trimeric CD23 and inhibits soluble CD23-induced IgE synthesis by B cells.
暂无分享,去创建一个
M. Kazatchkine | J. Bonnefoy | V. Frémeaux-Bacchi | J. Mani | S. Lecoanet‐Henchoz | E. Fischer | Jean-Claude Mani | Michel D. Kazatchkine | Véronique Fre ́ meaux-Bacchi | Elizabeth Fischer | J. Bonnefoy
[1] J. Galon,et al. Soluble Fcgamma receptor type III (FcgammaRIII, CD16) triggers cell activation through interaction with complement receptors. , 1996, Journal of immunology.
[2] M. Kazatchkine,et al. Human lymphocytes shed a soluble form of CD21 (the C3dg/Epstein‐Barr virus receptor, CR2) that binds iC3b and CD23 , 1996, European journal of immunology.
[3] A. Cross,et al. Interleukin‐2 binding proteins in sera from normal subjects and multiple sclerosis patients , 1995, Neurology.
[4] J. Atkinson,et al. Purification and functional properties of soluble forms of membrane cofactor protein (CD46) of complement: identification of forms increased in cancer patients' sera. , 1995, International immunology.
[5] J. Bonnefoy,et al. CD23/Fc epsilon RII and its soluble fragments can form oligomers on the cell surface and in solution. , 1995, Immunology.
[6] J. Bonnefoy,et al. CD23/CD21 interaction is required for presentation of soluble protein antigen by lymphoblastoid B cell lines to specific CD4+ T cell clones , 1994, European journal of immunology.
[7] M. Kazatchkine,et al. CR1(CD35) and CR2(CD21) complement C3 receptors are expressed on normal human thymocytes and mediate infection of thymocytes with opsonized human immunodeficiency virus , 1994, European journal of immunology.
[8] V. Holers,et al. CD23 interacts with a new functional extracytoplasmic domain involving N-linked oligosaccharides on CD21. , 1994, Journal of immunology.
[9] J. Bonnefoy,et al. Stimulation of human IgE production by a subset of anti-CD21 monoclonal antibodies: requirement of a co-signal to modulate epsilon transcripts. , 1994, Immunology.
[10] B. J. Sutton,et al. The human IgE network , 1993, Nature.
[11] H. Bazin,et al. Inhibition of an in vivo antigen-specific IgE response by antibodies to CD23. , 1993, Science.
[12] W. Prodinger,et al. Determination of soluble CD21 as a parameter of B cell activation , 1993, Clinical and experimental immunology.
[13] W. Ollier,et al. Variations in serum sCD23 in conditions with either enhanced humoral or cell-mediated immunity. , 1993, Immunology.
[14] M. Holder,et al. A subset of anti‐CD21 antibodies promote the rescue of germinal center B cells from apoptosis , 1993, European journal of immunology.
[15] J. Bonnefoy,et al. CD21 is a ligand for CD23 and regulates IgE production , 1992, Nature.
[16] A. Beavil,et al. Alpha-helical coiled-coil stalks in the low-affinity receptor for IgE (Fc epsilon RII/CD23) and related C-type lectins. , 1992, Proceedings of the National Academy of Sciences of the United States of America.
[17] N. Ling,et al. Cellular origins of serum complement receptor type 2 in normal individuals and in hypogammaglobulinaemia , 1991, Clinical and experimental immunology.
[18] M. Kazatchkine,et al. Expression of CR2 (the C3dg/EBV receptor, CD21) on normal human peripheral blood T lymphocytes. , 1991, Journal of immunology.
[19] D. Fearon,et al. Mapping of the Epstein-Barr virus and C3dg binding sites to a common domain on complement receptor type 2 , 1989, The Journal of experimental medicine.
[20] N. Cooper,et al. CR2 ligands modulate human B cell activation. , 1988, Journal of immunology.
[21] John D Lambris,et al. Expression of CR2/EBV receptors on human thymocytes detected by monoclonal antibodies , 1988, European journal of immunology.
[22] D. Fearon,et al. Synergistic interaction between complement receptor type 2 and membrane IgM on B lymphocytes. , 1988, Journal of immunology.
[23] J. Bonnefoy,et al. Interleukin 5 enhances interleukin 4‐induced IgE production by normal human B cells. The role of soluble CD23 antigen , 1988, European journal of immunology.
[24] D. Fearon,et al. Structure of the human B lymphocyte receptor for C3d and the Epstein- Barr virus and relatedness to other members of the family of C3/C4 binding proteins [published erratum appears in J Exp Med 1988 Nov 1;168(5):1953-4] , 1988, The Journal of experimental medicine.
[25] G. Nemerow,et al. Identification of gp350 as the viral glycoprotein mediating attachment of Epstein-Barr virus (EBV) to the EBV/C3d receptor of B cells: sequence homology of gp350 and C3 complement fragment C3d , 1987, Journal of virology.
[26] J. Diebold,et al. Human follicular dendritic cells express CR1, CR2, and CR3 complement receptor antigens. , 1985, Journal of immunology.
[27] Robert B Sim,et al. The generation of active fragments of complement receptor type 2 by trypsin digestion , 1985, FEBS letters.
[28] M. Kazatchkine,et al. Mouse monoclonal antibodies to the human C3b receptor. , 1985, Molecular immunology.
[29] M. Cooper,et al. Expression of C3d receptors during human B cell differentiation: immunofluorescence analysis with the HB-5 monoclonal antibody. , 1984, Journal of immunology.
[30] P. A. Biro,et al. Epstein-Barr virus receptor of human B lymphocytes is the C3d receptor CR2. , 1984, Proceedings of the National Academy of Sciences of the United States of America.
[31] D. Fearon,et al. Identification of a 145,000 Mr membrane protein as the C3d receptor (CR2) of human B lymphocytes. , 1984, Proceedings of the National Academy of Sciences of the United States of America.
[32] S. Newman,et al. Generation of three different fragments of bound C3 with purified factor I or serum. II. Location of binding sites in the C3 Fragments for Factors B and H, complement receptors , and bovine conglutinin , 1983, The Journal of experimental medicine.
[33] J. Saint-Remy,et al. Activation of the classical pathway of human complement by a human monoclonal IgE, IgE(DES). , 1983, Journal of immunology.
[34] J. Lambris,et al. Generation of three different fragments of bound C3 with purified factor I or serum. II. Location of binding sites in the C3 Fragments for Factors B and H, complement receptors , and bovine conglutinin , 1983, The Journal of experimental medicine.
[35] J. Schifferli,et al. Inhibition of immune precipitation by complement. , 1980, Clinical and experimental immunology.
[36] A. Beavil. α-Helical coiled-coil stalks in the low-affinity receptor for lgE(CD23/FcεRll) and related C-type lectins. , 1992 .
[37] D. Fearon,et al. Structure and function of the complement receptors, CR1 (CD35) and CR2 (CD21). , 1989, Advances in immunology.
[38] B. Myones,et al. Identification of a spontaneously shed fragment of B cell complement receptor type two (CR2) containing the C3d-binding site. , 1987, Complement.